RE Prenatal Multivitamin with Iron | RE Prenatal Multivitamin with Iron
RE Prenatal Multivitamins with Iron Chewable Tablets are wildberry-flavored prescription prenatal chewable vitamins.
RE Prenatal Multivitamins with Iron Chewable Tablets also contain polyethylene glycol, sugar, D/C Red #7 calcium lake, stearic acid, magnesium stearate, flavor, microcrystalline cellulose.
RE Prenatal Multivitamins with Iron Chewable Tablets are indicated to provide vitamin and mineral supplementation throughout pregnancy and during postnatal period for the lactating and non-lactating mother. It is also useful for improving the nutritional status prior to conception. RE Prenatal Multivitamins with Iron Chewable Tablets contains 1 mg folic acid, which is very important in the development of the baby’s spinal column during a specific period of time. Women are advised to start taking folate supplementation several weeks before conception and to continue taking them through the first 12 weeks of pregnancy, or longer. It is recommended that all women of childbearing years take supplements containing folic acid.
RE Prenatal Multivitamins with Iron Chewable Tablets are contraindicated in patients with known hypersensitivity to any of its ingredients. Folic acid (pteroylglutamic acid) is contraindicated in patients with untreated and uncomplicated pernicious anemia, and in those with anaphylactic sensitivity to folic acid. Iron therapy is contraindicated in patients with hemochromatosis and patients with iron storage disease or the potential for iron storage disease due to chronic hemolytic anemia (e.g., inherited anomalies of hemoglobin structure or synthesis and/or red cell enzyme deficiencies, etc.), pyridoxine responsive anemia or cirrhosis of the liver.
Pernicious anemia should be ruled out before starting treatment. While folic acid corrects the hematological profile of pernicious anemia, it does not ameliorate the underlying neurologic involvement.
Folic acid (pteroylglutamic acid) and Vitamin B microbiological blood assays are invalidated by the administration of most antibiotics, methotrexate and pyrimethamine. Folic acid (pteroylglutamic acid) is not effective reversing the toxic effects of methotrexate. Folic acid may partially correct the hematological damage due to deficiency of pernicious anemia, while the associated neurological damage progresses. In rare instances allergic sensitization has been reported following both oral and parenteral administration of folic acid.
Allergic sensitivity reactions and gastrointestinal disturbances may occur. By taking RE Prenatal Multivitamins with Iron Chewable Tablets shortly after meals. G.I. disturbances may be controlled.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
One tablet daily, or as directed by physician.
RE Prenatal Multivitamins with Iron Chewable Tablets are supplied as round, red tablets, debossed with “RE 388,” in bottles of 90 tablets, NDC# 68032-388-90.
Dispense in a tight, light-resistant container with a child resistant closure as defined by the USP.
Store at controlled room temperature 15°–30°C (59°–86°F). Protect from moisture and excessive heat.
River's Edge Pharmaceuticals, LLC
Drugs and Medications
NataFort PRENATAL MULTIVITAMIN TABLET WITH IRON
CitraNatalB-CalmRx Prenatal Vitamin with two 25 mg each Vitamin B tablets
Complete-RF PrenatalPrenatal Multivitamin & Multimineral Tablets
TriCare® Prenatal DHA ONE® Softgel
CitraNatalHarmony Rx Prenatal Vitamin Gel Cap
The purpose of this study is to determine safety and efficacy of prenatal iron supplementation in an area of high malaria burden among women who are not anemic or iron deficient.
In preterm infants with birth weights less than 1500 grams, does iron supplementation with 2mg/kg/day in addition to feeding with routine iron-fortified milk (formula or fortified mother's...
The purpose of this study is to determine whether a daily prenatal supplement of iron plus folic acid or a daily prenatal supplement with multiple vitamins and minerals given to women from...
This study is being done to compare arteriosclerotic cardiovascular disease in kidney transplant recipient taking a standard multivitamin versus those taking a multivitamin augmented by a ...
The study will determine whether a daily vitamin and mineral supplement (a multivitamin including Vitamin A) will improve health when added to standard chemotherapy for tuberculosis. This...
Micronutrient deficiency during pregnancy is associated with several complications. This study was designed to determine the effects of received multivitamin-mineral vs. multivitamin supplements on ma...
Despite widespread use of multivitamin supplements, their effect on cognitive health-a critical issue with aging-remains inconclusive. To date, no long-term clinical trials have studied multivitamin u...
Universal prenatal daily iron-folic acid (IFA) and multiple micronutrient (MM) supplements are recommended to reduce the risk of low birth weight, maternal anemia, and iron deficiency (ID) during preg...
Despite the efforts to reduce iron deficiency during pregnancy, information on the coverage and factors associated with utilization of iron supplements is lacking. The study is intended to assess the ...
Monoamine oxidase A (MAOA) gene polymorphisms resulting in high and low transcription rates are associated with individual differences in reward efficacy and response inhibition. Iron deficiency (ID)...